Patient Access to Investigational Drugs: Removing Barriers

PharmaVOICE Podcasts

Content provided by Daniel Limbach. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Daniel Limbach or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

11+ y ago

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on September 05, 2022 20:10 (1+ y ago). Last successful fetch was on May 12, 2019 01:16 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Thought Leader: Simon Estcourt, Senior VP, Strategy and Corporate Development, Idis
In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.
Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

127 episodes

#Medicine #Science #Pharma #Biotech #Clinical #Research #Drug #Daniel Limbach #Health and Well-Being #PharmaVOICE #Pharmaceutical